Chronic myeloid leukemia (CML) is a clonal disease of pluripotent hematopoietic cells characterized by the expression of the BCR/ABL1 fusion gene, which encodes a constitutively active tyrosine kinase BCR-ABL [1, 2]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.